Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) is now available.
ResMed Inc has filed a notice of proposed sale of securities, indicating the sale of 3,000 common shares with an aggregate market value of $812,310. The shares are scheduled for sale on the NYSE on September 2, 2025. This transaction involves shares acquired through options granted in 2018 and restricted stock vesting in 2022, reflecting strategic financial management and potential liquidity adjustments by the company’s officer, Brett Sandercock.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$47.25 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc is a company operating in the healthcare industry, primarily focusing on the development, manufacturing, and distribution of equipment related to sleep disorders and respiratory care. Their market focus includes providing solutions for sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions.
Average Trading Volume: 916,377
Technical Sentiment Signal: Buy
Current Market Cap: A$61.39B
Find detailed analytics on RMD stock on TipRanks’ Stock Analysis page.